Centre for Bioinnovation, University of the Sunshine Coastgrid.1034.6, Sippy Downs, Queensland, Australia.
Sunshine Coast Health Institute, Birtinya, Queensland, Australia.
Antimicrob Agents Chemother. 2022 May 17;66(5):e0020422. doi: 10.1128/aac.00204-22. Epub 2022 Apr 25.
The rise of antimicrobial-resistant (AMR) bacteria is a global health emergency. One critical facet of tackling this epidemic is more rapid AMR diagnosis in serious multidrug-resistant pathogens like Pseudomonas aeruginosa. Here, we designed and then validated two multiplex quantitative real-time PCR (qPCR) assays to simultaneously detect differential expression of the resistance-nodulation-division efflux pumps MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM, the AmpC β-lactamase, and the porin OprD, which are commonly associated with chromosomally encoded AMR. Next, qPCRs were tested on 15 sputa from 11 participants with P. aeruginosa respiratory infections to determine AMR profiles . We confirmed multiplex qPCR testing feasibility directly on sputa, representing a key advancement in AMR diagnosis. Notably, comparison of sputa with their derived isolates grown in Luria-Bertani broth (±2.5% NaCl) or a 5-antibiotic cocktail showed marked expression differences, illustrating the difficulty in replicating expression profiles . Cystic fibrosis sputa showed significantly reduced and expression compared with chronic obstructive pulmonary disease sputa, despite harboring fluoroquinolone- and aminoglycoside-resistant strains, indicating that these loci do not contribute to AMR was also significantly downregulated in cystic fibrosis sputa, even in the absence of contemporaneous carbapenem use, suggesting a common adaptive trait in chronic infections that may affect carbapenem efficacy. Sputum expression was highest in participants receiving carbapenems (6.7 to 15×), some of whom were simultaneously receiving cephalosporins, the latter of which would be rendered ineffective by the upregulated . Our qPCR assays provide valuable insights into the P. aeruginosa resistome, and their use on clinical specimens will permit timely treatment alterations that will improve patient outcomes and antimicrobial stewardship measures.
耐抗生素(AMR)细菌的兴起是全球健康紧急事件。应对这一流行疾病的一个关键方面是在严重的多药耐药病原体(如铜绿假单胞菌)中更快地进行 AMR 诊断。在这里,我们设计并验证了两个多重实时定量 PCR(qPCR)检测来同时检测耐药性调节和分隔外排泵 MexAB-OprM、MexCD-OprJ、MexEF-OprN 和 MexXY-OprM、AmpC β-内酰胺酶和孔蛋白 OprD 的差异表达,这些通常与染色体编码的 AMR 相关。然后,我们在 11 名铜绿假单胞菌呼吸道感染患者的 15 份痰液中测试了 qPCR ,以确定 AMR 谱。我们直接在痰液中证实了多重 qPCR 检测的可行性,这是 AMR 诊断的一个关键进展。值得注意的是,将痰液与在 Luria-Bertani 肉汤(±2.5%NaCl)或 5 种抗生素混合物中培养的衍生分离株进行比较,显示出明显的表达差异,表明复制表达谱存在困难。尽管携带氟喹诺酮类和氨基糖苷类耐药株,但囊性纤维化痰液的 和 表达明显低于慢性阻塞性肺疾病痰液,表明这些基因座不会导致 AMR。即使没有同时使用碳青霉烯类药物,囊性纤维化痰液中的 也明显下调,这表明在慢性感染中存在一种常见的适应性特征,可能会影响碳青霉烯类药物的疗效。接受碳青霉烯类药物治疗的患者痰液中的 表达最高(6.7 至 15 倍),其中一些患者同时接受头孢菌素治疗,上调的 会使后者无效。我们的 qPCR 检测为铜绿假单胞菌的耐药组提供了有价值的见解,它们在临床标本上的使用将允许及时改变治疗,从而改善患者的治疗效果和抗生素管理措施。